Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune
A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.
FDA to offer faster drug reviews to companies promoting 'national priorities'
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.
Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses
Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, supporting further development.
This Move Won't Stay Quiet for Long - Ad
They just made a $100M bet on blockchain. Early insiders are already circling.
Viatris Eye Drops Data Shows Promise For Blurred Near Vision
Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong patient-reported benefits.
States can cut off Medicaid funding to Planned Parenthood, the Supreme Court rules
WASHINGTON (AP) — A divided allowed states to cut off Medicaid money to Planned Parenthood in a ruling handed down Thursday amid a wider Republican-backed push to defund the country’s biggest abortion provider.
How high will Bitcoin go in 2025? - Ad
A new coin is emerging in the crypto bull market. Investing now could be like buying Bitcoin in 2013. Before it took off. Or scooping up Ethereum in 2017.. before it soared.
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
Nektar's rezpegaldesleukin met key efficacy targets in a mid-stage eczema study, though analysts flagged safety and differentiation concerns.
Louisiana files lawsuits alleging pharmaceutical giant CVS deceived customers in text messages
NEW ORLEANS (AP) — Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant market position to drive up drug costs and unfairly undermine independent pharmacies, the state’s attorney general said Tuesday.
3 Stocks to Buy Before Congress Approves the Pentagon's Record $1 Trillion Budget - Ad
43 days after President Trump won the election, the Chinese Communist Party sent him a very public warning. It was the Chinese military's real-life blueprint for destroying America's entire pacific fleet with the flip of a switch.
Wisconsin Supreme Court delivers win for environmentalists in fight over ‘forever chemicals’
MADISON, Wis. (AP) — The Wisconsin Supreme Court delivered a victory for environmentalists on Tuesday in the fight over “forever chemicals” known as PFAS.
FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.
Former Zillow Execs Target $1.3T Market - Ad
One co-founded Zillow. The other sold his company to Zillow for $120M. Now they're transforming a $1.3T market via co-ownership. Pacaso's already earned $110M+ in gross profit and reserved the Nasdaq ticker PCSO.
You probably don't need foods with added protein, nutritionists say
The human body needs protein. Proteins carry out countless functions inside cells and they are vital for the growth, repair and maintenance of muscles, bones and skin. And with food companies rolling out high-protein versions of a huge range of foods, including milkshakes and granola bars — and even pancakes and popcorn — you might be tempted to think you need to add more to your diet.
Why BlackRock is Hoarding 6X More Bitcoin Than Miners Produce - Ad
A Bitcoin supply shock is building. Institutions and ETFs are buying faster than miners can keep up - creating a shortage most investors haven't noticed. If Bitcoin hits $300K, altcoins could explode 1,000%+. We wrote Crypto Revolution to help you prepare.
FDA approves the world's only twice-a-year shot to prevent HIV
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S. and abroad to the powerful new option.
More employers are sending workers shopping for their own health coverage
A small, growing number of employers are putting decisions entirely in the hands of their workers.
Insider Buying. High Grades. and the Market Isn't Watching. - Ad
Billionaires. Bankers. Insiders. All backing a small explorer with 880M lbs CuEq and high- grades. Copper's breaking out. This might be the next big one.
Dutch government recommends children under 15 stay off TikTok and Instagram
THE HAGUE, Netherlands (AP) — The Dutch government advised parents on Tuesday not to have children under 15 use , citing psychological and physical problems among children using them, including panic attacks, depression and difficulties sleeping.
Hinge Health's Tech Is Primed To Capture America's Untapped MSK Pain Market: Analyst
Analysts initiate coverage of Hinge Health with Buy ratings, citing strong tech, recurring revenue, and a growing $18.5 billion MSK care market.
Trump's Tariffs Could Send This AI Stock Soaring - Ad
A little-known U.S. chipmaker just gained a major edge over foreign competitors thanks to Trump's new tariffs. We think demand is about to skyrocket -- and early investors could reap the biggest rewards.
Supreme Court order gives religious organizations new chance to challenge New York abortion rule
WASHINGTON (AP) — on Monday ordered a New York court to take a new look at whether some should be excluded from a state regulation requiring health insurance plans to cover abortions.
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
Sarepta suspends Elevidys use in non-ambulatory Duchenne patients after two liver failure deaths, triggering FDA review and clinical trial pause.
The Great Replacement: Why the Rich Are Fleeing Traditional Investments - Ad
Wall St icon Louis Navellier says the wealthy are moving millions into a new venture to escape "The Great Replacement"-a silent force wiping out traditional investments. Most Americans are unprepared. Find out where the ultra-rich are putting their money now.
When times are tough, practicing gratitude can improve moods in the workplace
NEW YORK (AP) — The first thing Alison Jones does when she wakes up is to name three things she’s grateful for. It can be as simple as the breeze from a fan or as meaningful as the way a friend showed up for her emotionally.
Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast
BofA raises Insmed price target to $109 after strong TPIP data and flags FDA decision on brensocatib as a near-term share catalyst.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Planet-warming emissions dropped when companies had to report them. EPA wants to end that
LEOPOLD, Ind. (AP) — On the ceiling of Abbie Brockman’s middle school English classroom in Perry County, the fluorescent lights are covered with images of a bright blue sky, a few clouds floating by.
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
A Bold Pivot Into Solana Is Here - Ad
This quiet NASDAQ company just made a move insiders say could be the next big crypto proxy.
Takeaways from AP examination showing benefits, costs of rules Trump EPA wants to change
The Environmental Protection Agency under President Donald Trump has served notice it wants to back away from at least 30 major rules that seek to protect air and water and reduce emissions that cause climate change. The agency's administrator, Lee Zeldin, says doing so would mean a new “golden age” for America.
Suspect in UnitedHealthcare CEO killing said he 'had it coming,' according to prosecutors
NEW YORK (AP) — Six weeks before was gunned down outside a Manhattan hotel in December, suspect Luigi Mangione mused about rebelling against “the deadly, greed fueled health insurance cartel” and said killing the executive “conveys a greedy bastard that had it coming,” prosecutors revealed Wednesday.
A Better Hedge Than Gold? - Ad
While the whole world is piling into gold as a hedge... White House documents reveal Trump is betting big on a completely under-the-radar resource. This little-known resource is minting 1,600 millionaires every single day... And investors have a rare opportunity to take advantage before everyone else catches on.
Texas considers banning products infused with THC derived from hemp, and retailers are worried
AUSTIN, Texas (AP) — Walk into enough gas stations and they’re likely easy to find: gummies, drinks and vapes infused with THC, the compound that gives marijuana its psychoactive properties.
Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report
Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff.
Solana-Backed Company Goes All In - Ad
A quiet $100M move could turn this overlooked firm into a blockchain market leader.
EU readying 'countermeasures' if tariffs deal with US crumbles
BARCELONA, Spain (AP) — The European Union on Monday said it is preparing “countermeasures” against the United States after the Trump administration's surprise rattled global markets and complicated the ongoing wider tariff negotiations between Brussels and Washington.
FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but on who can use it — not a replacement for the company’s existing shot, but a second option.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.